AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2020
Jan 6, 2020
31523_dirs_2020-01-06_a96547d2-77b2-43af-acdf-08373e965d14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-01-02
Reporting Person: Campbell Bradley L (Director, Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-02 | Common Stock | S | 2438 | $9.5611 | Disposed | 371329 | Direct |
Footnotes
F1: The sale of common stock was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $9.51 to $9.61. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.